"These studies, taken together, offer important insight into the direction we should be heading in prostate cancer diagnosis: toward a targeted-only TP biopsy," write Tarik Benidir, MD, and Zeyad Schwen, MD.
Zeyad Schwen, MD
Advertisement
Schwen is a urologist at Cleveland Clinic Glickman Urological and Kidney Institute in Ohio.
Articles by Zeyad Schwen, MD
Advertisement
Latest Updated Articles
The safety and oncologic benefits of transperineal vs transrectal MRI-guided prostate biopsyPublished: March 27th 2023 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
3
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
4
BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC
5
